Dendreon Corporation today announced that the company grew sales in four quarters successively, exceeded its revenue target for the first time ever, and achieved cash-flow break even in the fourth quarter (adjusted for non-recurring items), starting 2015 on a strong footing.
Sunovion Pharmaceuticals has filed patent infringement lawsuits against Emcure Pharmaceuticals Limited, Emcure Pharmaceuticals USA, Inc., and InvaGen Pharmaceuticals Inc. regarding their submissions of Abbreviated New Drug Applications for generic copies of Latuda®.
The drug mixture begins with the sedative midazolam and includes the same drugs used in Oklahoma's botched execution of Clayton Lockett in April. Lockett writhed on the gurney and moaned after he'd been declared unconscious.
CBS News chief medical correspondent Dr. Jon LaPook and medical contributor Dr. Tara Narula talk about the measles vaccine and how effective vaccines can be years after the drug is administered.
Vical Incorporated and AnGes MG announced today that they have entered into collaboration to develop and commercialize an equine polyclonal antibody therapy for patients afflicted with Ebola virus disease. No medicines or vaccines are currently approved for the treatment of Ebola.
SGS Life Science Services today announced that its laboratory in Poitiers, France, has successfully completed a full analytical validation of the novel Meso Scale Discovery (MSD®) V-PLEX 10-plex Proinflammatory Panel I, for use with human plasma samples.
The study assessed BRILINTA® (ticagrelor) tablets at either 60mg twice daily or 90mg twice daily plus low-dose aspirin for the secondary prevention of atherothrombotic events in patients who had experienced a heart attack one to three years prior to study start.
U.S. employers advertised the most job openings in nearly 14 years in November, the Labor Department said Tuesday. That suggests businesses are determined to keep adding staff because they are confident strong economic growth will create more demand for their goods and services.
Health officials say a federal laboratory technician who was possibly exposed to the Ebola virus did not get sick. Officials on Tuesday said the employee at the Centers for Disease Control and Prevention hasn't shown any symptoms since the incident Dec. 22.
Drug bioavailability is a major concern for all pharmaceutical companies. Being able to deliver the therapeutic benefits of the treatment at the right dosage and at the correct time and for the proper duration is a major stumbling block for any drug development program.
Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the development and commercialization of OP0595, a beta-lactamase inhibitor in phase I clinical development. Under the agreement, Roche obtains worldwide rights from both companies for development and commercialization with the exception of Japan, where Meiji will retain sole commercialization rights.
A federal judge has significantly reduced the nearly $2 million in damages awarded to a former teacher fired by a Roman Catholic diocese for trying to get pregnant through in vitro fertilization.
GlobalData: Rheumatoid Arthritis Treatment Market to be Transformed by Novel Drug and Biosimilar LaunchesJanuary 13, 2015 11:03 am | News | Comments
The global Rheumatoid Arthritis (RA) treatment market value will witness steady growth, from $15.6 billion in 2013 to $19.3 billion in 2023, at a Compound Annual Growth Rate (CAGR) of 2.1%, according to research and consulting firm GlobalData.
While Colorado and Washington have become ground zero for the incredible growth in legal marijuana usage, the states have also become safe havens for those that need easy access to medical marijuana.
Shares of Pharmacyclics jumped Tuesday morning after the cancer treatment developer announced better-than-expected revenue forecasts for Imbruvica, a leukemia drug it sells with a Johnson & Johnson subsidiary.